Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001144204-17-009023

Director nominations

  • Item 5.08 Shareholder director nominations

From the SEC's structured data for this filing

Loading v459525_8k.htm…